Chemoinformaics analysis of Disulfide, 1-methylpropyl propyl
| Molecular Weight | 164.339 | nRot | 5 |
| Heavy Atom Molecular Weight | 148.211 | nRig | 0 |
| Exact Molecular Weight | 164.069 | nRing | 0 |
| Solubility: LogS | -4.053 | nHRing | 0 |
| Solubility: LogP | 3.694 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 25 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 28.1587 |
| nHD | 0 | BPOL | 18.5113 |
| QED | 0.45 |
| Synth | 3.663 |
| Natural Product Likeliness | 1.021 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.152 |
| MDCK | 0.0000197 |
| BBB | 0.898 |
| PPB | 0.854699 |
| VDSS | 1.528 |
| FU | 0.160567 |
| CYP1A2-inh | 0.922 |
| CYP1A2-sub | 0.914 |
| CYP2c19-inh | 0.535 |
| CYP2c19-sub | 0.908 |
| CYP2c9-inh | 0.213 |
| CYP2c9-sub | 0.792 |
| CYP2d6-inh | 0.013 |
| CYP2d6-sub | 0.86 |
| CYP3a4-inh | 0.022 |
| CYP3a4-sub | 0.221 |
| CL | 13.622 |
| T12 | 0.315 |
| hERG | 0.021 |
| Ames | 0.049 |
| ROA | 0.072 |
| SkinSen | 0.813 |
| Carcinogencity | 0.399 |
| EI | 0.993 |
| Respiratory | 0.589 |
| NR-Aromatase | 0.006 |
| Antiviral | No |
| Prediction | 0.951664 |